glp-1 agonists names Best Med #2: Receptor — vim Performance Medicine GLP-1 Agonists: A Comprehensive Overview

In the Study of Tirzepatide in Participants with Heart Failure with Preserved Ejection Fraction with Obesity (SUMMIT) trial, tirzepatide significantly reduced the risk of death from cardiovascular causes or worsening heart failure events in patients with heart failure with preserved ejection fraction (ejection fraction 50% and above) and obesity (BMI 30 kg/m 2 ), compared with placebo (HR 0.62

Adapt it to your specific situation in consultation with your healthcare provider

doi: 10.3389/fimmu.2022.772446 27 RichardsPParkerHEAdriaenssensAEHodgsonJMCorkSCTrappSet al

doi: 10.1016/j.nlm.2010.02.002 56 BenedictCHallschmidMHatkeASchultesBFehmHLBornJet al

Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies